waiting, waiting,

waiting, waiting for news and so is everyone else by the looks of share volume in the last few days

Wish list: Alchemia fonda profit share in line with market expectation, positive phase III update just prior to release of details of Nasdaq listing, no CR, continuing positive market sentiment, phase II update indicating some effectiveness in targeting cancer stem cells

I live in hope but if more than half of the above occur this stock will be re-rated significantly